Cite Filings / LCTX / 0001193125-26-458487
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Lineage Cell Therapeutics, Inc. · Filed 2026-11-12 · Acc 0001193125-26-458487

Documents 1

  • 10-Q Quarterly Report , lctx-20260930.htm

Around this filing

  • 2026-11-19 4 Director bought 1,000,000 shares at $0.77 ($770,700)
  • 2026-11-17 4 Director bought 25,000 shares at $0.80 ($20,000)
  • 2026-11-17 4 President and CEO bought 40,500 shares at $0.92 ($37,098)
  • 2026-11-16 4 Chief Financial Officer bought 20,000 shares at $0.86 ($17,100)
  • 2026-11-12 10-Q Quarterly Report
  • 2026-11-12 8-K Material agreement · Acquisition or sale completed · Results of operations · Unregistered share sale · Regulation FD disclosure
  • 2026-08-06 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading lctx-20260930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…